# Mexiletine

## Meletin 100mg

| TAH Drug Code      | [OMELE](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMELE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ventricular arrhythmia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Initially， 400 mg as loading dose. Maintenance dose should be started 2-6 hours after initial dose. Usual daily dosage: 400-800 mg in 2-3 divided doses; maximum: 1200 mg/day.                                                                                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | 1. ventricular arrhythmias should never use this product within three months after myocardial infarction or when the cardiac output is insufficient (left ventricular output ratio is less than 35%) unless life-threatening. This product is contraindicated in patients with psychogenic shock or second or third stage atrioventricular conduction block without a pacemaker. 2. Hypersensitivity to this product or any excipients or local anesthetics (such as Lidocaine). 3. High degree of cardiac conduction blockage and no artificial frequency modulation device. |
| Adverse Effects    | Indigestion; hiccups; unpleasant taste， nausea， vomiting; joint pains; drowsiness， dizziness; confusion; disarticulated speech; blurred vision; nystagmus; tremor; paresthesia， ataxia; convulsions; hypotension， sinus bradycardia， atrial fibrillation， palpitations.                                                                                                                                                                                                                                                                                                |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/mexiletine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

